AbbVie touts more Rinvoq data in inflammatory spinal arthritis as it awaits key FDA decisions aliu Thu, 10/07/2021 – 10:37 More: AbbVie touts more Rinvoq data in inflammatory spinal arthritis as it awaits key FDA decisions Source: fierce
read moreAstraZeneca has submitted an emergency approval to the US drug regulators for its COVID-19 antibody cocktail, which would be the first non-vaccine protection from the virus to be granted approval. More: AstraZeneca pursues approval for COVID-19 antibody cocktail Source: News
read moreLeading RNA intereference (RNAi) therapeutics company, Alnylam, has been welcomed as the latest partner in the Medicines Manufacturing Innovation Centre, to transform the manufacturing process of oligonucleotide therapies. More: Alnylam becomes new partner in the Medicines Manufacturing Innovation Centre Source:
read morePilot launch complete: GlaxoSmithKline’s malaria shot scores WHO backing for wider rollout in Africa esagonowsky Wed, 10/06/2021 – 14:14 More: Pilot launch complete: GlaxoSmithKline's malaria shot scores WHO backing for wider rollout in Africa Source: fierce
read moreBiogen, mRNA players on Merck’s M&A radar as CEO still hungry for deals after $11.5B Acceleron buy: FT aliu Wed, 10/06/2021 – 11:31 More: Biogen, mRNA players on Merck's M&A radar as CEO still hungry for deals after .5B Acceleron
read moreBuyers clamor for Merck’s COVID-19 antiviral molnupiravir, but pricing is already controversial kdunleavy Wed, 10/06/2021 – 10:23 More: Buyers clamor for Merck's COVID-19 antiviral molnupiravir, but pricing is already controversial Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals